Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Oct 30;29(1):31–38. doi: 10.1158/1055-9965.EPI-19-0538

Figure 4.

Figure 4.

Kaplan–Meier estimates of 5-year overall survival for p16 IHC (A), HPV RNA-ISH (B), HPV DNA-ISH (C), HPV DNA-PCR (D), combined p16 IHC/HPV DNA-PCR (E), and combined p16 IHC/HPV RNA-ISH (F). Global differences in survival curves were compared through use of the log-rank test.